AtriCure Director Sven Wehrwein Receives 6,144 Restricted Stock Shares

This Form 4 filing reports that Sven Wehrwein, a director of AtriCure, Inc., acquired 6,144 shares of common stock on May 18, 2026. The shares were acquired at $0.00 per share as a Restricted Stock Award under the company's 2023 Stock Incentive Plan. According to footnote F1, these shares will vest upon the one-year anniversary of the grant date. Following this transaction, Wehrwein's total holdings increased to 40,518 shares. The filing was signed on May 20, 2026, by Allison Walker as attorney-in-fact for Sven Wehrwein. This represents a standard equity compensation award to a board member rather than a market purchase.